Coronary heart disease (Chd) in elderly patients: Which drug to choose, ticagrelor and clopidogrel? a systematic review and meta-analysis of randomized controlled trials
10.3390/jcdd8100123
Saved in:
Main Authors: | Akkaif, MA, Sha’aban, A, Daud, NAA, Yunusa, I, Ng, ML, Sk Abdul Kader, MA, Noor, DAM, Ibrahim, B |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
MDPI AG
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/207178 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The role of genetic polymorphism and other factors on clopidogrel resistance (Cr) in an asian population with coronary heart disease (chd)
by: Akkaif, MA, et al.
Published: (2021) -
A review of the effects of ticagrelor on adenosine concentration and its clinical significance
by: Akkaif, MA, et al.
Published: (2021) -
Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
by: Samman, KN, et al.
Published: (2021) -
Switching from Ticagrelor to Clopidogrel in Asian Patients with ST-Elevated Myocardial Infarction – A Time Dependent Analysis Study
by: Koh L, et al.
Published: (2020) -
Immature Platelet Level in Stable Coronary Heart Disease (CHD) Patients with Diabetes Mellitus compared to Stable CHD Patients without Diabetes Mellitus
by: D R Balti, -, et al.
Published: (2020)